Global Cell Cryopreservation Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Cell Cryopreservation Market is presumed to reach the market size of nearly USD 70.53 Billion by 2032 from USD 11.65 Billion in 2023 with a CAGR of 22.15% under the study period 2024 - 2032.

Cell cryopreservation is a technique used to preserve cells by freezing them at very low temperatures, typically in liquid nitrogen (-196 degrees Celsius or -321 degrees Fahrenheit) or in specialized cryopreservation solutions. This process allows cells to be stored for extended periods while maintaining their viability and functionality.

MARKET DYNAMICS

The Cell cryopreservation market is thriving due to the escalating importance of preserving cell viability across diverse applications. Medical advancements in organ transplantation, regenerative medicine, and assisted reproductive technologies are driving the adoption of cryopreservation for cells, particularly stem cells. The expansion of biobanks and their pivotal role in supporting research in cancer, genetics, and drug development significantly contributes to market growth. The continuous growth of assisted reproductive technologies, the development of cell-based therapies, and the integral role of cryopreserved cells in biopharmaceutical production are key drivers. Increased investments in research and development, coupled with technological advancements in cryopreservation methods, fuel demand. Cryopreservation's crucial role in conservation efforts, preventing the extinction of endangered species, adds to market dynamics. Furthermore, the globalization of healthcare, the rise in chronic diseases, and the impact of the COVID-19 pandemic on biotechnological solutions emphasize the market's significance. The Cell cryopreservation market is poised for continued expansion, underlining its critical role in advancing medical treatments, research, and biotechnological applications.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell cryopreservation. The growth and trends of cell cryopreservation industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the cell cryopreservation market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

Cryoprotectant Agents (Dimethyl Sulfoxide (DMSO), Ethylene Glycol, Glycerol, Other Agents)
Equipment (Freezers, Incubators, Liquid Nitrogen Supply Tanks, Cryopreservation Consumables)

By Cell Type

Stem Cells
Oocytes And Embryotic Cells
Sperm Cells
Hepatocytes
Other

By Application

Drug Discovery And Development
Regenerative Medicine
Organ Transplantation
Clinical Research
Other

By End-Use

Hospitals And Clinics
Biotechnology And Pharmaceutical Companies
Research And Academic Institutes
Contract Research Organizations (CROs)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cell Cryopreservation market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Cryopreservation market include Thermo Fisher Scientific Inc., Sartorius AG, PromoCell GmbH, BioLife Solutions Inc., Merck KGaA, HiMedia Laboratories, Creative Biolabs, Corning Incorporated, GE Healthcare, Danaher Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112113534

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . CELL CRYOPRESERVATION - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product Type
- 3.7.2 Market Attractiveness Analysis By Cell Type
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY PRODUCT TYPE

5.1 Overview by Product Type
5.2 Historical and Forecast Data
5.3 Analysis by Product Type
5.4 Cryoprotectant Agents (Dimethyl Sulfoxide (DMSO), Ethylene Glycol, Glycerol, Other Agents) Historic and Forecast Sales by Regions
5.5 Equipment (Freezers, Incubators, Liquid Nitrogen Supply Tanks, Cryopreservation Consumables) Historic and Forecast Sales by Regions

6 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY CELL TYPE

6.1 Overview by Cell Type
6.2 Historical and Forecast Data
6.3 Analysis by Cell Type
6.4 Stem Cells Historic and Forecast Sales by Regions
6.5 Oocytes And Embryotic Cells Historic and Forecast Sales by Regions
6.6 Sperm Cells Historic and Forecast Sales by Regions
6.7 Hepatocytes Historic and Forecast Sales by Regions
6.8 Other Historic and Forecast Sales by Regions

7 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY APPLICATION

7.1 Overview by Application
7.2 Historical and Forecast Data
7.3 Analysis by Application
7.4 Drug Discovery And Development Historic and Forecast Sales by Regions
7.5 Regenerative Medicine Historic and Forecast Sales by Regions
7.6 Organ Transplantation Historic and Forecast Sales by Regions
7.7 Clinical Research Historic and Forecast Sales by Regions
7.8 Other Historic and Forecast Sales by Regions

8 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY END-USE

8.1 Overview by End-use
8.2 Historical and Forecast Data
8.3 Analysis by End-use
8.4 Hospitals And Clinics Historic and Forecast Sales by Regions
8.5 Biotechnology And Pharmaceutical Companies Historic and Forecast Sales by Regions
8.6 Research And Academic Institutes Historic and Forecast Sales by Regions
8.7 Contract Research Organizations (CROs) Historic and Forecast Sales by Regions

9 . GLOBAL CELL CRYOPRESERVATION MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1. Overview, Historic and Forecast Data Sales Analysis
- 9.3.2. North America By Segment Sales Analysis
- 9.3.3. North America By Country Sales Analysis
- 9.3.4. United State Sales Analysis
- 9.3.5. Canada Sales Analysis
- 9.3.6. Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1. Overview, Historic and Forecast Data Sales Analysis
- 9.4.2. Europe by Segment Sales Analysis
- 9.4.3. Europe by Country Sales Analysis
- 9.4.4. United Kingdom Sales Analysis
- 9.4.5. France Sales Analysis
- 9.4.6. Germany Sales Analysis
- 9.4.7. Italy Sales Analysis
- 9.4.8. Russia Sales Analysis
- 9.4.9. Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1. Overview, Historic and Forecast Data Sales Analysis
- 9.5.2. Asia Pacific by Segment Sales Analysis
- 9.5.3. Asia Pacific by Country Sales Analysis
- 9.5.4. China Sales Analysis
- 9.5.5. India Sales Analysis
- 9.5.6. Japan Sales Analysis
- 9.5.7. South Korea Sales Analysis
- 9.5.8. Australia Sales Analysis
- 9.5.9. South East Asia Sales Analysis
- 9.5.10. Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1. Overview, Historic and Forecast Data Sales Analysis
- 9.6.2. Latin America by Segment Sales Analysis
- 9.6.3. Latin America by Country Sales Analysis
- 9.6.4. Brazil Sales Analysis
- 9.6.5. Argentina Sales Analysis
- 9.6.6. Peru Sales Analysis
- 9.6.7. Chile Sales Analysis
- 9.6.8. Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1. Overview, Historic and Forecast Data Sales Analysis
- 9.7.2. Middle East & Africa by Segment Sales Analysis
- 9.7.3. Middle East & Africa by Country Sales Analysis
- 9.7.4. Saudi Arabia Sales Analysis
- 9.7.5. UAE Sales Analysis
- 9.7.6. Israel Sales Analysis
- 9.7.7. South Africa Sales Analysis
- 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE CELL CRYOPRESERVATION COMPANIES

10.1. Cell Cryopreservation Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11 . COMPANY PROFILES OF CELL CRYOPRESERVATION INDUSTRY

11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Thermo Fisher Scientific Inc.
- 11.3.1. Company Overview
- 11.3.2. Company Revenue
- 11.3.3. Products
- 11.3.4. Recent Developments
11.4. Sartorius AG
- 11.4.1. Company Overview
- 11.4.2. Company Revenue
- 11.4.3. Products
- 11.4.4. Recent Developments
11.5. PromoCell GmbH
- 11.5.1. Company Overview
- 11.5.2. Company Revenue
- 11.5.3. Products
- 11.5.4. Recent Developments
11.6. BioLife Solutions Inc.
- 11.6.1. Company Overview
- 11.6.2. Company Revenue
- 11.6.3. Products
- 11.6.4. Recent Developments
11.7. Merck KGaA
- 11.7.1. Company Overview
- 11.7.2. Company Revenue
- 11.7.3. Products
- 11.7.4. Recent Developments
11.8. HiMedia Laboratories
- 11.8.1. Company Overview
- 11.8.2. Company Revenue
- 11.8.3. Products
- 11.8.4. Recent Developments
11.9. Creative Biolabs
- 11.9.1. Company Overview
- 11.9.2. Company Revenue
- 11.9.3. Products
- 11.9.4. Recent Developments
11.10. Corning Incorporated
- 11.10.1. Company Overview
- 11.10.2. Company Revenue
- 11.10.3. Products
- 11.10.4. Recent Developments
11.11. GE Healthcare
- 11.11.1. Company Overview
- 11.11.2. Company Revenue
- 11.11.3. Products
- 11.11.4. Recent Developments
11.12. Danaher Corporation
- 11.12.1. Company Overview
- 11.12.2. Company Revenue
- 11.12.3. Products
- 11.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies